| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 1997 | 2019 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1976 | 1983 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1997 | 2017 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2006 | 2014 | ||||||||
|
basal cell adhesion molecule (Lutheran blood group) | 0.666 | 0.462 | 1.1E-08 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2007 | 2013 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2014 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
disease | 0.040 | None | 1.000 | 3 | 1 | 2006 | 2009 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2009 | 2017 | ||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2013 | |||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2005 | ||||||||
|
protein tyrosine phosphatase non-receptor type 6 | 0.485 | 0.769 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 1999 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
microRNA 150 | 0.455 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2010 | |||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2018 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 1152 | 0.729 | 0.231 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2007 | |||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2012 | 2012 | ||||||||
|
nectin cell adhesion molecule 1 | 0.523 | 0.808 | 6.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2009 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2014 | ||||||||
|
CD63 molecule | 0.542 | 0.731 | 1.7E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
interleukin 3 | 0.489 | 0.731 | 2.6E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2009 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2016 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2017 |